Vaccine Execs Rake In $1 Billion In Stock Sales As Positive Headlines Boost Shares 2020/07/27 19:13:35 Zero Hedge
Vaccine Execs Rake In $1 Billion In Stock Sales As Positive Headlines Boost Shares Tyler Durden Mon, 07/27/2020 - 15:13 With the race to find a vaccine for COVID-19 in full effect, biotech executives and other insiders from at least 11 companies have made hand over fist - raking in over $1 billion in stock sales after announcing positive developments, according to the New York Times . In some cases, company insiders are profiting from regularly scheduled compensation or automatic stock trades. But in other situations, senior officials appear to be pouncing on opportunities to cash out while their stock prices are sky high . And some companies have awarded stock options to executives shortly before market-moving announcements about their vaccine progress. -NYT In May, we noted that insiders at Moderna cashed out on some $30 million in options - while CEO Stephane Bancel has become a billionaire. Moderna CEO Stéphane Bancel The company's market value is now nearly $30 billion thanks to a stream of positive press releases, while insiders have sold around $248 million altogether since January - most of it coming following an April announcement that the company had been selected to receive federal funding to support their efforts. 1/ It is good to be Stephane Bancel, CEO of Moderna.
Published National Findings in Lyme Disease Testing to Be Discussed on July 30 Webinar Hosted by Quidel Corporation 2020/07/21 19:22:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)--Elizabeth Lee-Lewandrowski, Ph.D., MPH, to discuss findings of a national seven-year study on Lyme disease testing on a webinar on Thursday, July 30.
The Daily Biotech Pulse: Opko Wins CDC Contract, Novartis Lowers Guidance, Pieris Study Placed On Partial Clinical Hold 2020/07/21 11:58:40 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX ) AstraZeneca plc (NYSE: AZN ) ( announced positive Phase 1/2 readout for the coronavirus vaccine it is co-developing with the Oxford University) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) Beigene Ltd (NASDAQ: BGNE ) BIO-TECHNE Corp (NASDAQ: TECH ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) (reacted to positive late-stage readout for BXCK501 in treating schizophrenia and bipolar disorder) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) CALLIDITAS THER/S ADR (NASDAQ: CALT ) Catalent Inc (NYSE: CTLT ) Cytosorbents Corp Inc (NASDAQ: CTSO ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Emergent Biosolutions Inc (NYSE: EBS ) Fortress Biotech (NASDAQ: FBIO ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Heat Biologics Inc (NASDAQ: HTBX ) Illumina, Inc.
Quidel’s Sofia® SARS Antigen FIA Updates EUA Performance Data to 96.7% PPA Versus PCR; Product Supports U.S. Initiatives to Expand Access to COVID-19 Testing in Nursing Homes; Receives CE Mark for Use With Sofia® and Sofia® 2 Instruments 2020/07/18 03:00:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has updated the performance data for its Sofia® SARS Antigen FIA test on its package insert to 96.7% using direct nasal swab specimens versus PCR as a result of further studies included in its amended Emergency Use Authorization (EUA) that were submitted to the U.S. Food and Drug A
5 Stock Gainers for Friday: VBI Vaccines, Moderna, Novavax 2020/07/17 20:23:27 The Street
Stocks trading higher Friday include VBI Vaccines, Moderna, Novavax, Dynavax Technologies, and Quidel.
Quidel Corporation to Host Free Webinar Addressing the Prevention, Detection and Treatment of Lyme Disease 2020/06/16 15:15:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)-- #deertick--Quidel Corporation will host an important webinar addressing the prevention, detection and treatment of Lyme disease on June 25.
We spoke to 3 financial experts, who broke down why you should buy these 13 ETFs to maximize stock-market returns right now 2020/06/11 12:26:15 Business Insider
With the stock market climbing off multiyear lows, investors are seeking opportunities in a market that's confounded even the top Wall Street strategists. One way to gain diverse exposure to a basket of companies, rather than individual stocks, is to purchase exchange-traded funds. Business Insider interviewed three ETF experts to get their top picks for funds designed to play themes ranging from international equities, to healthcare, to video games and esports. Click here to sign up for our weekly newsletter Investing Insider . Click here for more BI Prime stories . US equity markets have recovered a large chunk of losses absorbed amid the coronavirus pandemic. That's largely due to the Federal Reserve's lowering of interest rates to near zero, as well as its continued commitment to mammoth quantitative easing efforts. Surprisingly positive economic data in recent days has also been a source of the optimism driving markets. As the rebound has played out, some experts have questioned whether the market is overvalued and have argued that the current risk-reward ratio is too high. "For me personally, it's an uncomfortable bet to continue to bet on a huge recovery," Allianz Chief Economic Advisor Mohamed El-Erian said on CNBC Monday morning, for instance.
Global GAS Pharyngitis Diagnostics Market Analysis to 2027, Featuring Key Players Quidel Corporation, BD, bioMrieux SA and Meridian Bioscience, Inc. 2020/06/10 17:00:00 PR Newswire
DUBLIN, June 10, 2020 /PRNewswire/ -- The "GAS Pharyngitis Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering. This report on the global GAS pharyngitis diagnostics market…
Knowing Signs and Symptoms of Lyme Disease Is Critical for Early Detection and Treatment, Says Industry-Leading Quidel 2020/06/02 15:00:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)-- #lymedisease--Industry-leading Quidel Corporation says knowing the signs and symptoms of Lyme disease is critical for early detection and treatment.
The Zacks Analyst Blog Highlights: Chegg, Bandwidth, Wayfair, Quidel and Atlas Air Worldwide 2020/06/01 13:50:00 Zacks Investment Research
The Zacks Analyst Blog Highlights: Chegg, Bandwidth, Wayfair, Quidel and Atlas Air Worldwide
Quidel’s Lyra® Direct SARS-CoV-2 Assay Submitted for Emergency Use Authorization for Molecular Detection of COVID-19, Without Extraction Step 2020/04/22 21:00:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has applied for an Emergency Use Authorization (EUA) for the Lyra® Direct SARS-CoV-2 Assay from the Food and Drug Administration (FDA) to allow direct sample processing. The assay will be run on the same six different instruments as the Lyra® SARS-CoV-2 Assay. Lyra® Direct Removes
Quidel (QDEL) is an Incredible Growth Stock: 3 Reasons Why 2020/04/14 16:45:12 Zacks Investment Research
Quidel (QDEL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests 2020/04/01 11:38:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) Athersys Inc (NASDAQ: ATHX ) Forty Seven Inc (NASDAQ: FTSV ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Quidel Corporation (NASDAQ: QDEL ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 31) Aikido Pharma Inc (NASDAQ: AIKI ) BIOLASE Inc (NASDAQ: BIOL ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Gritstone Oncology Inc (NASDAQ: GRTS ) Neovasc Inc (NASDAQ: NVCN )(moved in reaction to its fourth quarter results) Opko Health Inc. (NASDAQ: OPK ) Phio Pharmaceuticals Corp (NASDAQ: PHIO )(announced $4 million registered offering) Second Sight Medical Products Inc (NASDAQ: EYES ) Related Link: Amarin Analysts React To Vascepa Patent Loss, See Small Chance Of Overturning Judgment Stocks In Focus Inflarx Begins Human Testing Of Lead Drug For COVID-19-induced Pneumonia German biopharma Inflarx NV (NASDAQ: IFRX ) said it has enrolled and dosed the first patient into a randomized clinical trial investigating the safety and efficacy of IFX-1 , its monoclonal anti-C5a antibody in patients with severe COVID-19-induced pneumonia.
FDA OKs emergency use of Quidel coronavirus test on three systems 2020/03/26 10:37:24 Seeking Alpha
The FDA has issued Emergency Use Authorizations for the use of Quidel's (NASDAQ:QDEL) Lyra SARS-CoV-2 Assay with the following thermocyclers (instruments t